- Home
- CNP vs TEVA Comparison
CNP vs TEVA Comparison
Compare CNP & TEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNP
- TEVA
- Stock Information
- Founded
- CNP 1866
- TEVA 1901
- Country
- CNP United States
- TEVA Israel
- Employees
- CNP N/A
- TEVA N/A
- Industry
- CNP Electric Utilities: Central
- TEVA Biotechnology: Pharmaceutical Preparations
- Sector
- CNP Utilities
- TEVA Health Care
- Exchange
- CNP Nasdaq
- TEVA Nasdaq
- Market Cap
- CNP 24.6B
- TEVA 21.2B
- IPO Year
- CNP N/A
- TEVA N/A
- Fundamental
- Price
- CNP $39.27
- TEVA $20.02
- Analyst Decision
- CNP Buy
- TEVA Strong Buy
- Analyst Count
- CNP 12
- TEVA 7
- Target Price
- CNP $39.04
- TEVA $25.57
- AVG Volume (30 Days)
- CNP 5.8M
- TEVA 10.3M
- Earning Date
- CNP 10-23-2025
- TEVA 11-05-2025
- Dividend Yield
- CNP 2.23%
- TEVA N/A
- EPS Growth
- CNP N/A
- TEVA N/A
- EPS
- CNP 1.43
- TEVA N/A
- Revenue
- CNP $8,982,000,000.00
- TEVA $16,628,000,000.00
- Revenue This Year
- CNP $6.90
- TEVA $4.07
- Revenue Next Year
- CNP $3.97
- TEVA $0.81
- P/E Ratio
- CNP $27.52
- TEVA N/A
- Revenue Growth
- CNP 4.84
- TEVA 2.08
- 52 Week Low
- CNP $28.57
- TEVA $12.47
- 52 Week High
- CNP $40.50
- TEVA $22.80
- Technical
- Relative Strength Index (RSI)
- CNP 59.19
- TEVA 61.37
- Support Level
- CNP $38.02
- TEVA $19.87
- Resistance Level
- CNP $40.50
- TEVA $20.61
- Average True Range (ATR)
- CNP 1.02
- TEVA 0.61
- MACD
- CNP 0.08
- TEVA 0.05
- Stochastic Oscillator
- CNP 33.23
- TEVA 75.12
About CNP CenterPoint Energy Inc (Holding Co)
CenterPoint Energy owns a portfolio of businesses. Its regulated electric utilities provide transmission and distribution services to more than 2.5 million customers in the Houston area, southern Indiana, and west central Ohio. The company has natural gas distribution systems serving approximately 4 million customers.
About TEVA Teva Pharmaceutical Industries Limited
Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.